Trials / Completed
CompletedNCT02169921
TurboHawk™ Japan Trial in Patients With PAD
Determination of Safety and Effectiveness of the TurboHawk and the SpiderFX for the Treatment of Peripheral Arterial Disease in the Superficial Femoral and/or the Popliteal Arteries in Japan
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 51 (actual)
- Sponsor
- Medtronic Endovascular · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to evaluate the safety and effectiveness of the TurboHawk for the treatment of peripheral arterial disease (PAD) in the superficial femoral and/or the popliteal arteries with the Japanese population.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Atherectomy Catheter | Atherectomy Catheter, TurboHawk, is used for Angioplasty. Spider FX can concomitantly be used with TurboHawk. TurboHawkTM LS-C, TurboHawk LX-C, TurboHawk SS-CL and TurboHawk SX-C are participated in this arm. |
Timeline
- Start date
- 2014-06-01
- Primary completion
- 2015-09-01
- Completion
- 2016-05-01
- First posted
- 2014-06-23
- Last updated
- 2019-04-16
Locations
2 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT02169921. Inclusion in this directory is not an endorsement.